Charles W. Newhall III, Director of Supernus Pharmaceuticals SUPN, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $1.3M. The latest trade was on 02/24.

CI

CI

Charles W. Newhall III

Director

Company

Supernus Pharmaceuticals SUPN

First filing

23/02/24

Trades

29 trades

Buys / sales

0 / 7

12-month net buying

−$1.3M

Last trade

02/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/10/09	25/10/10	25,000 sh2 trades	$50.77avg.	$1,269,234	−19.3%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/08/27	25/08/29	3,588 sh	$45.01	$161,495.88	−2.7%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/08/25	25/08/27	1,000 sh	$45.00	$45,000	−0.7%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/08/22	25/08/26	1,412 sh	$45.00	$63,540	−1.0%
Supernus PharmaceuticalsSUPN	Open-market sale	24/11/11	24/11/12	10,700 sh	$36.24	$387,768	−7.6%
Supernus PharmaceuticalsSUPN	Open-market sale	23/11/16	23/11/20	2,500 sh	$28.01	$70,025	−2.1%